Argus•January 20, 2021

NEO: What does Argus have to say about NEO?

Symbols

NEO

Sector(s)

Healthcare

Rating

Premium

Current Price

$53.17

Price Target

$NaN

Earnings Estimate

Premium

Summary

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland.

Premium

Subscribe to Yahoo Finance Premium for full access

Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.

Try Premium FREE

Actions

Download Full Report

Related Reports

DVA: Lowering target price to $126.00
Feb 24, 2021 •
DVA
GKOS: What does Argus have to say about GKOS?
Feb 24, 2021 •
GKOS
Weekly Stock List
Feb 22, 2021 •
DD, BHF, TGNA, CTVA, FISV, SNAP, BMY, QSR, HOLX, CMCSA, T, ELAN, ATVI, LH, GE, NLOK, FE, XRX
DVA: Lowering target price to $127.00
Feb 17, 2021 •
DVA
GKOS: Lowering target price to $76.00
Feb 17, 2021 •
GKOS

View more related reports